DrugPatentWatch Database Preview

Alpharma Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA, and when can generic versions of ALPHARMA drugs launch?

ALPHARMA has sixty-three approved drugs.

There are nine US patents protecting ALPHARMA drugs.

Summary for Alpharma

US Patents:	9
Tradenames:	45
Ingredients:	42
NDAs:	63
Patent Litigation for Alpharma:	See patent lawsuits for Alpharma

Drugs and US Patents for Alpharma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-003	Aug 13, 2009		RX	Yes	No	8,685,444		Y
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009		RX	Yes	No	8,846,104		Y
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009		RX	Yes	No	7,815,934		Y
Alpharma Us Pharms	LOPERAMIDE HYDROCHLORIDE	loperamide hydrochloride	SOLUTION;ORAL	073187-001	Sep 15, 1992		DISCN	No	No
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-005	Aug 13, 2009		RX	Yes	No	7,815,934		Y
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009		RX	Yes	No	8,877,247		Y

Expired US Patents for Alpharma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-005	Aug 13, 2009	5,378,474
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-004	Aug 13, 2009	5,378,474
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-003	Aug 13, 2009	5,202,128
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009	5,202,128
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	4,620,974

Paragraph IV (Patent) Challenges for ALPHARMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Capsules	30 mg/1.2 mg, 50 mg/2 mg and 80 mg/3.2 mg		2010-05-28
	Extended-release Capsules	100 mg/4 mg		2010-05-03
	Extended-release Capsules	60 mg/2.4 mg		2010-05-25

International Patents for Alpharma Drugs

Country	Document Number	Estimated Expiration
Spain	2600141
European Patent Office	2422773
Canada	2655835
Denmark	2719378
Mexico	2008016372
European Patent Office	2422775

Supplementary Protection Certificates for Alpharma Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB12/047	United Kingdom		PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
C0038	France		PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB98/013	United Kingdom		PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
C/GB12/058	United Kingdom		PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
C0012	France		PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Alpha Thera
• Alpharma
• Alpharma Pharms
• Alpharma Us Pharms